Glutathione 1200mg
99.0% HPLC PurityResearch-grade Glutathione (GSH) 1200mg lyophilised powder. 99.0% HPLC purity, COA verified. Endogenous antioxidant tripeptide for research.

SKU: PW-004 • Batch: PW-260304
Research-grade GHK-Cu 50mg lyophilised powder. 99.3% HPLC purity, COA verified. Copper peptide complex for wound healing and skin research.
Read the full description ↓✓Free shipping on orders over $750 AUD
✓Tracked international post — Standard $39.99 / Express $69.99 AUD
✓Dispatched next business day (orders before 11PM AEST)
Research-grade Glutathione (GSH) 1200mg lyophilised powder. 99.0% HPLC purity, COA verified. Endogenous antioxidant tripeptide for research.
Purity independently verified by an accredited third-party laboratory via HPLC & mass spectrometry.
GHK-Cu (Copper peptide GHK-Cu) is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. Originally isolated from human plasma, it is one of the most extensively studied copper peptide complexes in biomedical research. Supplied as a lyophilised powder at 99.3% HPLC purity with full Certificate of Analysis.
Research has explored GHK-Cu for roles in wound healing, collagen and elastin synthesis stimulation, anti-inflammatory signalling, angiogenesis promotion, and antioxidant activity. The copper ion is integral to its biological activity, coordinating with the three amino acid residues to form the active complex.
The 50mg size provides research efficiency for extended study protocols. The reconstituted solution characteristically appears blue-green due to the copper complex. This is normal and expected.
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is studied in preclinical research for its role in wound repair, skin remodelling, anti-inflammatory responses, and angiogenesis. For in-vitro laboratory research use only.
Our GHK-Cu 50mg is independently verified at 99.3% HPLC purity with full COA documentation including copper complex identity confirmation.
The 50mg size provides greater research flexibility and cost efficiency per milligram for labs conducting extended studies. It remains stable in lyophilised form for extended periods when properly stored.
Store at −20°C in lyophilised form. Once reconstituted, store at 2–8°C and use within 4 weeks, protected from light.
Add bacteriostatic water (BAC water) slowly to the vial and gently swirl to dissolve. The solution should appear slightly blue-green due to the copper complex. This is expected and normal.
Yes, every batch ships with a full COA including HPLC purity %, mass spectrometry, copper complex confirmation, sterility, and endotoxin data.
GHK-Cu 50mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable laws and regulations.
No questions yet — be the first to ask about this product.
Exclusive KLOW proprietary multi-peptide blend 50mg lyophilised. 99.0% purity, COA verified. Advanced synergistic peptide research formula exclusive to Peptide Labs.
Research-grade Retatrutide 10mg lyophilised powder. 99.4% HPLC purity, COA verified. Triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
Recent peer-reviewed studies from PubMed related to GHK-Cu. Provided for research context — not medical advice.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A · International journal of molecular sciences · 2018
PMID: 29986520
The potential of GHK as an anti-aging peptide
Dou Y, Lee A, Zhu L, et al. · Aging pathobiology and therapeutics · 2020
PMID: 35083444
Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective
Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR · BioImpacts : BI · 2025
PMID: 39963574
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?
Ogórek K, Nowak K, Wadych E, et al. · Molecules (Basel, Switzerland) · 2025
PMID: 39795193
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.